In vitro and in vivo photosensitizing applications of Photofrin® in malignant melanoma cells

Chang Gung Medical Journal

Volumn 31, Issue 3, 2008, Pages 260-267

  Chang, Cheng Jen ^a,b   Yu, Jau Song ^a   Wei, Fu Chan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Malignant melanoma; Photodynamic therapy (PDT); Photosensitizer

Indexed keywords

PHOTOFRIN;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL CULTURE; CELL KILLING; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ABSORPTION; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIHEMATOPORPHYRIN ETHER; FEASIBILITY STUDIES; MELANOMA; MICE; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 45249103522     PISSN: 02558270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Spikes JD. The historical development of ideas on applications of photosensitized reactions in the health sciences. In: Benasson RV, Jori G, Land EJ, Truscott TG, eds. Primary Photo-Processes in Biology and Medicine. NY: Plenum Press, 1985:209-27.
2. Nelson JS, Liaw LH, Berns MW. Mechanism of tumor destruction in photodynamic therapy. Photochem Photobiol 1987;46:829-36.
3. Nelson JS, Liaw LH, Orenstein A, Robert WG, Berns MW. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorine and phthalocyanine. J Natl Cancer Inst 1988;80:1599-605.
4. He DP, Hamption JA, Keok R, Selman SH. Photodynamic therapy: Effect on the endothelial cell of rat aorta. Photochem Photobiol 1991;54:801-4.
5. Berns MW, Hammer-Wilson M, Walter RJ, Wright WH, Chow MH, Nahabedian M, Wile A. Uptake and localization of HpD and active fraction in tissue culture and in serially biopsied human tumors. Adv Exp Med Bio 1983;170:501-20.
6. Foote CS. Photosensitized oxidation and singlet oxygen: Consequences in biological systems. In Pryor WA, ed. Radicals in Biology. Vol. 2. NY: Academic Press, 1976:85-102.
7. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 1976;36:2326-9.
8. Berns MW, Coffey J, Wile AG. Laser photoradiation therapy of cancer: possible role of hyperthermia. Lasers Surg Med 1984;4:87-92.
9. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation Therapy II-hematoporphyrin and light. J Natl Cancer Inst 1975;55:115-21.
10. Nelson JS, Liaw LH, Berns MW. Tumor destruction in photodynamic therapy. Photochem Photobiol 1987;46:829-35.
11. Nelson JS, Wright WH, Berns MW. Histopathological comparison of the effects of hematoporphyrin derivative on two different murine tumors using computer-enhanced digital video fluorescence microscopy. Cancer Res 1985;45:5781-6.
12. Nelson JS, Berns MW. Biological studies on the main fractions of hematoporphyrin derivative. Cancer Res 1987;47:1027-30.
13. Gibson SL, Hilf R. Interdependence of fluence, drug dose and oxygen on hematoporphyrin derivate induced photosensitization of tumor mitochondria. Photochem Photobiol 1985;42:367-73.
14. Salet C, Moreno G. Photosensitization of mitochondria. Molecular and cellular aspects. J Photochem Photobiol B 1990;5:133-50.
15. Dellinger M. Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem Photobiol 1996;64:182-7.
16. Hsieh YJ, Wu CC, Chang CJ, Yu JS. Subcellular localization of photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets. J Cell Physiol 2003;194:363-75.
17. Peng TI, Chang CJ, Guo MJ, Wang YH, Yu JS, Wu HY, Jou MJ. Mitochondrion-targeted photosensitizer enhances the photodynamic effect-induced mitochondrial dysfunction and apoptosis. Ann NY Acad Sci 2005;1042:419-28.
18. Chang CJ, Lee YH, Yang JY, Weng CJ, Wei FC. Pilot intro toxicity study of 5-ALA and Photofrin® in microvascular endothelial cell cultures. J Clin Laser Med Surg 1997;15:83-7.
19. Chang CJ, Ma SF, Wei FC. Photosensitizing capabilities of Photofrin® in vascular endothelial cells. Formosa J Surg 2001;34:287-93.
20. Chang CJ, Sun CH, LHL Liaw, Nelson JS, Berns MW. In vitro and in vivo photosensitizing capabilities of 5-ALA compared to Photofrin® in vascular endothelial cells. Lasers Surg Med 1999;24:178-86.
21. Jarrett A, Riminton C, Willoughby DA. Deltaaminolevulinic acid and porphyria. Lancet 1956;270:125-7.
22. Shanley BC, Taljaard JJ, Deppe WM, Joubert SM. Deltaaminolevulinic acid in acute porphyria. S Afr Med J 1972;46:864.
23. Gaullier JM, Geze M, Santus R, Sa e Melo T, Maziere JC, Bazin M, Morliere P, Dubertret L. Subcellular localization of and photosensitization by protoporphyrin IX in human keratinocytes and fibroblasts cultivatived with 5-aminolevulinic acid. Photochem Photobiol 1995;62:114-22.
24. Gullino PM, Grantham FH. The influence of the host and the neoplastic cell population on the collagen content of a tumor mass. Cancer Res 1963;23:648-53.
25. Tsai JC, Hsiao YY, Teng LJ, Chen CT, Kao MC. Comparative study on the ALA photodynamic effects of human glioma and meningioma cells. Lasers Surg Med 1999; 24:296-305.
26. Muller P. PDT for primary brain tumor. Photodynamic News 1999;2:2-5.
27. Kaneko S. Stereotactic intratumoral PDT for malignant brain tumors. Photodynamic News 1999;2:8-10.
28. Rovers JP, de Jode ML, Grahn MF. Significantly increased lesion size by using the near-infrared photosensitizer 3, 10, 15, 20-tetrakis (m-hydroxyphenyl) bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue. Lasers Surg Med 2000;27:235-40.
29. Lin XX, Wang W, Wu SF, Yang C, Chang TS. Treatment of capillary vascular malformation (port-wine stains) with photochemotherapy. Plast Reconstr Surg 1997;99:1826-30.